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ABSTRACT
Small nucleolar RNAs (snoRNAs) function mainly as
guides for the post-transcriptional modification of
ribosomal RNAs (rRNAs). In recent years, several
studies have identified a wealth of small fragments
(<35nt) derived from snoRNAs (termed sdRNAs)
that stably accumulate in the cell, some of which
may regulate splicing or translation. A comparison
of human small RNA deep sequencing data sets
reveals that box C/D sdRNA accumulation
patterns are conserved across multiple cell types
although the ratio of the abundance of different
sdRNAs from a given snoRNA varies. sdRNA
profiles of many snoRNAs are specific and
resemble the cleavage profiles of miRNAs. Many
do not show characteristics of general RNA deg-
radation, as seen for the accumulation of small
fragments derived from snRNA or rRNA. While
53% of the sdRNAs contain an snoRNA box C
motif and boxes D and D0 are also common in
sdRNAs (54%), relatively few (12%) contain a full
snoRNA guide region. One box C/D snoRNA,
HBII-180C, was analysed in greater detail, revealing
the presence of C0 box-containing sdRNAs com-
plementary to several pre-messenger RNAs (pre-
mRNAs) including FGFR3. Functional analyses
demonstrated that this region of HBII-180C can
influence the alternative splicing of FGFR3
pre-mRNA, supporting a role for some snoRNAs
in the regulation of splicing.
INTRODUCTION
Small nucleolar RNAs (snoRNAs) are a class of con-
served RNAs identiﬁed as guides for site-speciﬁc
post-transcriptional modiﬁcations in ribosomal RNA
(rRNA) (1–4). snoRNAs are ubiquitous throughout eu-
karyotes and have also been detected in a subset of
archaea (5–6). Two main classes of snoRNAs have been
characterized: the box C/D snoRNAs, most of which
guide 20-O-ribose methylation of their RNA targets and
the box H/ACA snoRNAs that guide pseudouridine
modiﬁcations.
Human box C/D snoRNA molecules are typically 70–
120nt in length and mainly encoded in the introns of
protein-coding genes. They can be excised from introns
through at least two distinct pathways, then are further
processed and bound by conserved proteins including
the 20-O-methyl transferase ﬁbrillarin (4,7). Box C/D
snoRNAs are characterized by the presence of two,
short conserved motifs, the C box (UGAUGA) and the
D box (CUGA), found near the 50 and 30-ends of the
molecule, respectively (Figure 1A). Both boxes are
required for snoRNA processing and localization (4).
In the folded box C/D snoRNA molecule, boxes C and
D come into close proximity and serve as a binding site for
interacting proteins. A second pair of boxes, referred to as
C0 and D0, can often be found closer to the middle of box
C/D snoRNAs, but display lower conservation than the
boxes C and D (2,8) (Figure 1B). The guide region that is
complementary to the RNA target is located immediately
50 to the box D or D0 regions; also called an antisense box,
the guide sequence base pairs with the target forming
an RNA–RNA duplex. The nucleotide targeted for
methylation is usually base paired with the ﬁfth residue
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Although targets have been found for many human box
C/D snoRNAs, mainly in rRNA, numerous orphan
snoRNAs have also been described, for which no target
has been identiﬁed (4,9). Furthermore, recent reports
suggest additional roles for snoRNAs and indicate that
a subset of snoRNAs may be processed into smaller
fragments.
The largest family of orphan box C/D snoRNAs
described to date in human is the HBII-52 family that
consists of 47 members and is expressed from the
SNURF–SNRPN locus (11,12). Most members of the
HBII-52 family display complementarity to the serotonin
receptor 2C transcript and cause changes in its splicing
patterns in transfection experiments (13). More recently,
the MBII-52 family, the mouse homologue of the HBII-52
family, was shown to be processed into smaller fragments,
some of which regulate the alternative splicing of ﬁve
distinct endogenous transcripts (11). In addition to the
HBII-52 family involved in splicing regulation, several
human box C/D snoRNAs were shown to play a role in
translation regulation, another non-canonical function for
an snoRNA. Originally described for a subset of human
box H/ACA snoRNAs (14), several studies have now es-
tablished a relationship between speciﬁc snoRNAs and
microRNAs (miRNAs), in both human and Giardia
lamblia. These include snoRNAs and miRNAs found to
be colocalized in the genome, as well as snoRNAs with
miRNA capabilities and miRNA precursors with
snoRNA-like features (15–18).
miRNAs are short RNAs of  22nt in length, processed
out of longer hairpins, and typically involved in transla-
tion repression of mRNAs, generally mediated in ani-
mals by base pairing to the 30-UTR of their targets (19).
Consistent with reports of a relationship between
miRNAs and snoRNAs, processed fragments derived
Figure 1. Predicted secondary structure and conservation of the human HBII-180 box C/D snoRNAs. (A) The characteristic features of the box C/D
snoRNA HBII-180C are illustrated including conserved C and D motifs indicated by orange and cyan boxes, respectively. The guide region
(complementary to 28S rRNA) is displayed in pink and the position of the M-box region is shown in blue. (B) Screenshot of the UCSC
Genome Browser (10) displaying the mammalian conservation and alignment of HBII-180C, encoded in chromosome 19 in an intron of gene
C19orf48.
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sdRNAs), with a similar size to mature miRNAs, have
been detected in numerous small RNA sequencing data
sets [for example refs (20–22)]. Analysis of human small
RNAs detected from the acute monocytic leukemia cell
line THP-1 and from frozen prefrontal cortex tissue
showed stronger accumulation of small fragments from
the 50-end of box C/D snoRNAs than the 30-end (22,23).
A smaller scale study of processed box C/D snoRNAs
showed accumulation of functionally tested miRNA-like
fragments derived from both the 50- and 30-ends of the
snoRNA (15). Consistent with a precursor–product rela-
tionship between snoRNAs and certain miRNAs, several
reports have identiﬁed miRNAs accumulating in the
nucleus and even speciﬁcally in the nucleolus (18,24–26).
Here, we explore the diversity and conservation of pro-
cessing and accumulation of small RNAs <35nt (referred
to as sdRNAs) derived from box C/D snoRNAs by
analysis of multiple deep-sequencing small RNA data
sets. We also describe a box C/D snoRNA, HBII-180C,
processed into sdRNAs and potentially involved in the
regulation of splicing.
MATERIALS AND METHODS
Data sets
The 14 small RNA data sets considered are described
in Table 1. For the NPC 5-8F data set, the nuclear and
cytoplasmic sequence counts were combined and
considered simultaneously. Small RNA sequences
from these 14 data sets were mapped to known human
box C/D snoRNA sequences downloaded from
snoRNAbase (27). When mapping, we required perfect
matching for the entire fragment but did not require the
fragments to map uniquely to the human genome, because
many box C/D snoRNA families include either identical,
or near-identical copies.
Secondary structure, conservation, annotation and
alignment of box C/D snoRNAs
RNA secondary structures were predicted by
RNAstructure 4.6 (32) and annotated using RnaViz 2.0
(33). The mammalian conservation of HBII-180C was
calculated and visualized using the Vertebrate Multiz
Alignment and PhastCons Conservation utilities (34–36).
The sequence and position of characteristic features of
box C/D snoRNAs were obtained from snoRNABase
(27) and sno/scaRNAbase (37). Alignment of sdRNAs
and their corresponding snoRNA were visualized using
Jalview (38).
Counts of fragments containing characteristic snoRNA
features
To determine the proportion of sdRNAs-containing char-
acteristic box C/D snoRNA features, the sequences of the
boxes C, D and D0, as well as the guide regions, were
manually obtained from the sno/scaRNAbase (37), when
available. snoRNAs were only considered if they were rep-
resented by at least 10 sdRNA counts in at least 10 of the
deep-sequencing data sets (Table 1). In total, 87 box C/D
snoRNAs were analysed. The proportion of counts con-
taining each of the characteristic features were calculated
for each snoRNA and averaged over all snoRNAs
considered.
Processing patterns of box C/D snoRNAs
To systematically investigate processing patterns of box
C/D snoRNAs, all full-length snoRNAs were divided
50–30 into 10% sequence blocks as previously done (22),
thus normalizing for varying length. For a given cell type,
all sdRNAs detected were mapped to parental snoRNAs
Table 1. Small RNA data sets considered
Data set name GEO series and platforms or data set link Cell type details References
hESC Link from Genome Research
website, see publication
H9 hESCs (21)
EB H9 human embryoid bodies
Centroblast GSE23090
GPL9115
Derived from human tonsil (28)
Centrocyte
Naı¨ve B cell
Plasma cell
Pre-germinal centre B cell
Memory B cell
THP-1 GSE20664
GPL9115
Human monocytic leukaemia cell line (22,29)
NPC 5-8F GSE22918
GPL9052
Human NPC 5-8F cells (25)
PBMC GSE19833
GPL9052
Human normal PBMCs (30)
K562 Human chronic myelogenous leukaemia cell line
HL60 Human acute promyelocytic leukaemia cell line
HepG2 GSE14362
GPL9115
Human liver carcinoma cell line (31)
3678 Nucleic Acids Research, 2012,Vol.40, No. 8and counted in the 10% block from which the 50-end of
the sdRNA originates. The counts for each block were
then normalized by the total number of sdRNA counts
detected in the cell type examined, yielding a relative
abundance value for each block. When an sdRNA
mapped to more than one snoRNA, it was only con-
sidered once to avoid count duplication. sdRNAs typically
map to more than one snoRNA from the same family,
which display very similar lengths, thus a random assign-
ment of an sdRNA to one of several parental snoRNAs
of the same family is possible for this analysis. However,
for the average processing analysis (Figure 2B), because
every snoRNA proﬁle is considered, sdRNAs were
assigned to all snoRNAs to which they map. When
comparing absolute counts of sdRNAs mapped to a
speciﬁc full-length snoRNA (Figure 4), counts were
normalized by counts per million reads mapped to the
human genome for each data set. For a given data set,
the number of reads mapped to the human genome (NCBI
build 37) was determined using Bowtie (39) with the
option ‘–n 0’.
Cell culture and transfection
HeLa, WI-38 and HepG2 cells were maintained in
Dulbecco’s-modiﬁed Eagle’s medium supplemented with
10% fetal bovine serum (FBS). THP-1, K562 and HL60
cells were maintained in RPMI 1640 with L-glutamine and
10% FBS. All plasmid transfections were performed using
effectin (Invitrogen) as described by the supplier.
RNase protection assays
RNase protection assays were performed using the
mirVana
TM miRNA Detection Kit (Ambion). Full-
length HBII-99B, U31, HBII-419, HBII-142, U14A and
U24 snoRNAs were
32P labelled according to the manu-
facturer’s protocol. Labelled probes were mixed with
HepG2, THP-1, K562 or HL60 cell total RNAs, respect-
ively, and RNase treatment was performed according to
the manufacturer’s protocol.
Detection of FGFR3 isoform
RNA was isolated by the TRIzol method with DNase I
treatment, according to the manufacturer’s instructions
(Invitrogen). RT–PCR was performed to detect target
RNAs. Reverse transcription and PCR were performed
with the following gene-speciﬁc primers:
FGFR3: 50-TGGACGTGCTGGAGCGCTCCCCGC-30
and 50-CCCAGGGTCAGCCGGGCCCGAGACAG-30,
FGFR38–10: 50-TGGACGTGCTGGAGCGCTCCCC
GC-30 and 50-CCCAGGGTCAGCCGGGCCCGAGA
CAG-30,
GAPDH: 50-CGCATCTTCTTTTGCGTCGCCAG-30
and 50-GGTCAATGAAGGGGTCATTGATGGC-30,
HBII-180C: 50-CTCCCATGATGTCCAGCACT-30 and
50-CTCAGACCCCCAGGTGTCAA-30,
U3: 50-AGAGGTAGCGTTTTCTCCTGAGCG-30 and
50-ACCACTCAGACCGCGTTCTC-30.
To decide the linearity of cycles, we performed real-time
PCR using the Superscript III Platinum SYBR Green
one-step qRT–PCR kit (Invitrogen) and Rotor-Gene
RG-3000 system (Corbett Research). The same amount
of RNA was used as templates for RT–PCR reactions.
Each experiment was repeated three times independently.
We also performed real time PCR using the QuantiFast
SYBR Green RT–PCR kit (QIAGEN) and LightCycler
480 II (Roche). FGFR3 8–10 signals were normalized
by U3 signals as a loading control. Each experiment was
repeated three times independently.
RESULTS
Relative position of stably accumulating sdRNAs
To characterize the processing of box C/D snoRNAs
and investigate whether the distribution of stably
accumulating snoRNA-derived fragments is cell type
Figure 2. Provenance of sdRNAs from within full-length box C/D
snoRNAs in 14 diverse human cell types. (A) Relative abundance of
the 50 position of sdRNAs within full-length box C/D snoRNAs. To
normalize for non-uniform distribution of snoRNA length, the 50-ends
of all box C/D sdRNAs detected in a given cell type were mapped and
counted in 10% blocks of their respective full-length snoRNAs. For each
cell type investigated, the abundance of sdRNAs mapped to a speciﬁc
block was normalized by the total number of counts of all sdRNAs
detected in that cell type and this relative abundance was plotted as a
function of relative position within the full-length snoRNAs, as
described in the ‘Materials and Methods’ section. (B) To investigate
average sdRNA abundance as a function of snoRNA position for all
snoRNAs individually, the relative abundance per block was calculated
as above for each snoRNA and averaged over all snoRNAs. The error
bars represent standard deviation. Only snoRNAs with sdRNA counts
of at least 10 were considered for this analysis.
Nucleic Acids Research,2012, Vol.40, No. 8 3679speciﬁc, we analysed the contents of 14 diverse publically
available human small RNA deep-sequencing data sets
(described in the ‘Materials and Methods’ section and in
Table 1). To facilitate comparison of the different data
sets, we considered only small RNAs mapping perfectly
to box C/D snoRNAs and determined for each data set
the relative abundance of such fragments as a function of
their position in the full-length snoRNA. SnoRNAs were
only considered if they had at least 10 counts in at least
10 of the different data sets and thus 87 of the 269 human
box C/D snoRNAs were investigated for this analysis.
As shown in Figure 2A, while several data sets display a
predominant accumulation of sdRNAs from the 50-end of
the full-length snoRNAs [as reported previously for the
THP-1 cell line (22)], others show a stronger accumulation
of sdRNAs from the middle of the full-length molecules.
This analysis does not preclude that fragments derived
from a small number of snoRNAs represent the bulk of
the counts and the distribution shown might not be rep-
resentative of the majority of snoRNAs. To investigate
this possibility and gain a better understanding of the dis-
tribution of box C/D snoRNA processing, we considered
the relative abundance and position of sdRNAs for each
snoRNA and averaged over all box C/D snoRNAs.
As shown in Figure 2B, across all data sets examined,
the processing patterns and accumulation of sdRNAs
display signiﬁcant differences between snoRNAs, as
demonstrated by the large standard deviations. For 10
of the data sets considered, averaged over all snoRNAs,
<50% of the small fragments are derived from the 50-end
of the snoRNA, while at least as many sdRNAs originate
from the middle and 30-end of the molecule. The variabil-
ity of origin of the sdRNAs mapping to the 30 side of the
main hairpin likely ﬁnds its source in the diversity of struc-
ture of snoRNAs.
Processing patterns of box C/D snoRNAs in different
cell types
We next sought to investigate whether snoRNA process-
ing is conserved in different cell types, on a per snoRNA
basis. To do so, the abundance versus position proﬁles
of sdRNAs from the 14 data sets investigated above
were compared for individual snoRNAs. For a given
snoRNA, data sets were included only if counts of at
least 10 sdRNAs were detected.
For most box C/D snoRNAs, sdRNAs originate from a
small number of positions that are conserved between the
different data sets, suggesting the processing pathways in
use are common for the cell types considered (Figure 3).
However, the relative abundance of the sdRNAs varies
between the data sets and typically, while sdRNAs from
a speciﬁc region on the 50 side of the main hairpin show
the highest abundance in some cell types, sdRNAs
mapping to a speciﬁc region on the 30 side of the main
hairpin accumulate more strongly in other cell types. For
example, for the box C/D snoRNA U31, H9 embroid
bodies (EB), H9 human embryonic stem cells (hESC),
naı¨ve B cells, centroblasts, peripheral blood mononuclear
cells (PBMC), nasopharyngeal carcinoma cells (NPC
5-8F), HL60, THP-1, memory B cells, HepG2 and K562
cells display a strong accumulation of sdRNAs from the
50- end of the molecule (shown with the green line in the
predicted structure). In contrast, centrocytes, plasma cells
and pre-germinal B cells display a stronger accumulation
from the 30 side of the hairpin (beginning at positions
51–60% of the full-length molecule, the approximate
position of this sdRNA within the full-length snoRNA
is shown with a purple line in the predicted structure).
These patterns indicate that while the snoRNAs undergo
cleavage and processing in a conserved way in different
cell types, the ratio of accumulation of speciﬁc fragments
is cell type speciﬁc.
The predominant sdRNAs often contain a box C or C0
(for example the sdRNAs shown with green lines in
HBII-99B, HBII-142, U24 and U31 and the sdRNAs
shown with purple lines in HBII-142, U14A and U24 in
Figure 3). Averaged over all snoRNAs that have counts of
at least 10 in at least 10 of the data sets considered, 53% of
sdRNAs contain the box C and 54% contain a box D0
or D. In contrast, regions of complementarity to rRNA
are either absent, or only present at low frequency in the
most abundant sdRNAs (seen for all snoRNAs examined
in Figure 3 except HBII-99B) and on average, only 12% of
sdRNAs contain complete-guide regions.
Conserved processing versus degradation
Next, we computationally addressed whether the sdRNAs
are likely to result from general RNA degradation, rather
than speciﬁc processing resulting in functional smaller
molecules. To do this, sdRNA accumulation proﬁles of
individual snoRNAs were analysed on a per residue
basis and, as a control, compared with proﬁles of other
abundant, structured small nuclear RNAs. sdRNA accu-
mulation proﬁles are often highly conserved across the cell
types examined and display well-deﬁned sdRNAs with
conserved start and end positions, both within and
across most cell types (Figure 4A and Supplementary
Figure S1). Several of the snoRNA proﬁles, in particular
of HBII-419, U24 and HBII-99B (Figure 4A), resemble
processing proﬁles of well-validated miRNAs (Figure
4B), consistent with directed cleavage. In contrast, pro-
cessing proﬁles displayed by abundant nuclear RNAs
transcribed by either RNA polymerase II or III, and not
known to serve as precursors for smaller functional RNA
molecules (rRNA and snRNA; Figure 4C) are poorly
conserved between cell types and highly variable, with
no strong accumulation of either identical, or highly
overlapping, small RNA molecules. They instead have
proﬁles more consistent with general cleavage and exo-
nuclease digestion (for example the highest peak in the
U6 plot, Figure 4C). In contrast, over all box C/D
snoRNAs considered, approximately half display only
one predominant and well-deﬁned sdRNA type conserved
in at least 10 data sets, as seen for miRNAs in Figure 4B.
We also examined whether the sdRNA fragments cor-
relate speciﬁcally with high-GC content hairpin regions
that may be generally more resistant to degradation. The
average GC content of full-length box C/D snoRNAs with
at least 10 counts in 10 of the data sets considered is
0.43±0.06. The average GC content of their sdRNAs is
3680 Nucleic Acids Research, 2012,Vol.40, No. 8Figure 3. Processing patterns of representative box C/D snoRNAs. The relative abundance of the 50-ends of sdRNAs as a function of position in the
full-length snoRNA was calculated as described for Figure 2 and in the ‘Materials and Methods’ section for each cell line and cell culture considered
and then plotted as a heatmap. Red indicates a high proportion of sdRNAs whose 50-end maps to a speciﬁc 10% block while white indicates an
absence of sdRNAs mapping to a speciﬁc block. Predominant sdRNAs are typically represented by a red vertical trace indicating a high proportion
of sdRNA 50-ends map to this block in most cell types. Predominant sdRNAs are colour-coded using green, purple and yellow circles below the
processing patterns section, which correspond to a line of matching colour in the predicted structure, indicating the approximate position of the
sdRNA in the structure. Characteristic snoRNA features derived from refs (27,37) are annotated on the predicted structures including boxes C and
C0 highlighted in orange and boxes D0, D and guide regions highlighted in cyan.
Nucleic Acids Research,2012, Vol.40, No. 8 3681also 0.43±0.08. Therefore sdRNAs do not arise speciﬁc-
ally from high-GC content regions. In summary, the data
are not consistent with all sdRNAs arising though general
RNA degradation.
As the 14 sequencing data sets considered were genera-
ted in several different laboratories, we also sought to
conﬁrm our analyses of the processing of a subset of
snoRNAs using an independent method. We thus
carried out RNase A/T1 protection assays for 6 box
C/D snoRNAs (HBII-419, U31, HBII-142, HBII-99B,
U24 and U14A) for four of the commercially available
cell lines considered in our deep sequencing analysis
(HepG2, THP-1, K562 and HL60). The results show
that the length of the sdRNA fragments identiﬁed by
deep-sequencing (shown in Figure 5A and
Supplementary Figures S2–S6) typically match closely
Figure 4. Accumulation proﬁles of diverse small RNAs. The accumulation proﬁles of subsets of (A) snoRNAs, (B) miRNAs and (C) rRNA as well
as snRNAs were examined across a range of cell types (D). The x-axis on all graphs represents residue positions in the full-length (precursor)
molecule. The y-axis represents the number of smaller fragments detected, that contain a speciﬁc residue in the full-length molecule, normalized by
counts per million reads mapped. The miRNAs chosen (B) are those with the highest number of validated targets according to miRecords (40) that
were detected in at least 10 of the 14 cell types examined. snRNAs were also chosen to ensure representation in at least 10 cell types. The lengths of
the predominant fragments are shown in panels A and B above the graphs.
3682 Nucleic Acids Research, 2012,Vol.40, No. 8with the sizes of the fragments protected in the RNase
protection assays (shown by arrow heads of Figure 5B
and Supplementary Figures S2–S6). In some cases, the
results are more difﬁcult to interpret because of the ex-
pression level of sdRNAs and also the presence of
non-speciﬁc bands of the same size as the expected frag-
ments. Overall, however, the RNase protection data
support the results obtained above from analysis of
RNA deep-sequencing data.
HBII-180C processing
The HBII-180s are a family of closely related human box
C/D snoRNAs, which contain a region of complemen-
tarity to 28S rRNA immediately upstream from the
box D0 that is common to all members of this family.
Three human HBII-180 members (A–C) are encoded in
separate introns of the same gene, C19orf48 (41).
Though the exons of this gene display low conservation
throughout mammals, HBII-180 snoRNAs are well
conserved as illustrated in Figure 1B. In addition to the
characteristic conserved boxes, HBII-180 members also
contain a region of near perfect complementarity to en-
dogenous pre-messenger RNA (pre-mRNA) sequences,
termed the M-box (41). The M-box region is not highly
conserved among HBII-180 members.
While snoRNAs HBII-180A and HBII-180B are
expressed at low levels in all cell types examined,
HBII-180C displays higher expression and accumulation
of sdRNAs. Analysis of small RNA data sets demon-
strates that three main sdRNA forms accumulate from
HBII-180C, (Figure 6B and C). While some cell types
display almost uniquely the 50 sdRNA form (see THP-1
and HepG2 in Figure 6B and C), others show a strong
accumulation of either the middle, or 30 fragments. Similar
to numerous other box C/D snoRNAs, including those
shown in Figure 3, HBII-180C sdRNAs are derived
from regions containing not only the boxes D0 and D
but also from regions containing the boxes C and C0
(Figure 6C). A subset of fragments detected from
HBII-180C contain either a full, or partial, M-box as
reported previously (26), and this accumulation is cell
type speciﬁc. We recently reported a detailed analysis of
the M-box fragment, i.e. production of sdRNA from
HBII-180C, including an RNase protection assay, expres-
sion of the HBII-180C M box fragment for both endogen-
ous and overexpression of HBII-180C and analysis of the
localization pattern of both the M box fragment and
full-length HBII-180C (26). Careful examination of the
sequences of the sdRNAs (Figure 6C) suggests a potential
cleavage position for the processing of the full-length
HBII-180C (drawn in Figure 6A).
HBII-180C targets and alternative splicing of FGFR3
Although potential functional relationships between
snoRNA M-box sequences and the endogenous cellular
RNAs to which they are complementary remain to be
established, we have shown that it is possible to reduce
expression of both the mRNA and protein levels of
a targeted gene of interest by altering the snoRNA
M-box region to make it complementary to the chosen
gene (41).
A scan of the genomic sequences of all human protein
coding genes using the full-length HBII-180C snoRNA
reveals that the top two reverse complementary hits cor-
respond to intronic sequences in the genes HIPPI (refseq
nucleotide accession number NM_018010) and FGFR3
(NM_000142) (41). These regions display either perfect,
or near-perfect, complementarity to the M-box of
HBII-180C, as shown in Figure 7A. As the expression of
the gene HIPPI is generally low in most cell types, making
experimental investigation difﬁcult, we therefore
concentrated on testing the possibility of a functional re-
lationship between HBII-180C snoRNA and FGFR3
pre-mRNA.
First, we investigated whether altering expression of
HBII-180C snoRNA can inﬂuence the expression of alter-
natively spliced FGFR3 isoforms using an antisense
approach. Plasmid vectors encoding either a wild-type
(FR3), or mutant (FRm), sequence that spans the region
within FGFR3 intron 17 targeted by HBII-180C
(described in Figure 7B), were transiently expressed in
HeLa cells under the control of the cytomegalovirus
(CMV) promoter. PCR analysis of FGFR3 mRNA
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Figure 5. Detection of endogenous U14A sdRNA fragments. The
fragments processed from the box C/D snoRNA U14A as identiﬁed
by deep sequencing were compared to endogenous U14A sdRNAs
detected by RNase A/T1 protection assays. (A) Distribution of
fragment lengths obtained by deep sequencing for U14A in the THP-1,
HL60 and K562 cell lines. (B) Detection of endogenous sdRNA frag-
ments by RNase A/T1 protection assay in the HepG2, THP-1, HL60 and
K562 cell lines. As a control for the RNase protection assays, the diluted
antisense probe against U14A was loaded without RNase digestion
(probe lane). For each cell line, the probes were incubated with
increasing amounts of total RNA (0, 1, 5, 10mg, respectively, for lanes
2–5, and for lanes 6–9). Both the mature snoRNAs (arrow) and shorter
fragments (arrow heads) were protected from RNase A/T1 digestion.
Nucleic Acids Research,2012, Vol.40, No. 8 3683expression showed that transient overexpression of the
intron 17 fragment that is complementary to HBII-180C
resulted in an increase in the levels of a spliced FGFR3
isoform called 8–10 (42) that is normally expressed at
low levels in HeLa cells (Figure 7C, compare lanes 1 and
2). This change in the expression pattern of FGFR3
isoforms is not observed upon expression of either the
empty vector alone, or of the vector expressing the same
intron 17 sequence with a 4nt change in the middle of the
region complementary to HBII-180C (Figure 7C, lanes 1
and 3). In addition, the overexpression of wild-type
HBII-180C reduced the expression level of the FGFR3
8–10 isoform but the overexpression of the HBII-180C
box D mutant did not (Figure 7D). We next investigated
the expression levels of FGFR3 isoforms in WI38 (human
lung primary cells) and HeLa cells to see if there is any
correlation between FGFR3 splicing pattern and
HBII-180C expression without transient transfection. As
shown in Figure 7E, the presence of the smaller isoform of
FGFR3 inversely correlates with the abundance of
HBII-180C.
In summary, we conclude that the presence of
HBII-180C snoRNA can affect the alternative splicing
of FGFR3 pre-mRNA by decreasing the accumulation
of the 8–10 isoform.
DISCUSSION
Full-length snoRNAs have been extensively investigated
and their role in the site-speciﬁc, post-transcriptional
modiﬁcation of rRNA and other nuclear RNAs described.
In the past 3 years, independent studies have identiﬁed the
stable accumulation of short RNA fragments derived
from snoRNAs. These studies range from experimental
AB
C
Figure 6. Processing pattern of HBII-180C. (A) The predicted structure of HBII-180C is shown with boxes C and C0 highlighted in orange and boxes
D0, D and guide regions highlighted in cyan. (B) Processing patterns of HBII-180C, derived as described in Figure 3. (C) Sequence alignment of
HBII-180C and all its sdRNAs detected in cell types considered. Nucleotides are colour-coded: A (green), C (orange), G (red) and T (blue).
3684 Nucleic Acids Research, 2012,Vol.40, No. 8characterizations of individual snoRNAs [for example refs
(11,14)] to large scale analyses of small RNA data sets [for
example (20,22,23)], and the description of snoRNA-
derived fragments resembling other known small RNAs,
such as miRNAs (15,17,18,24,25). While originally
regarded only as likely degradation products, the diversity
of organisms in which snoRNA-derived fragments have
been detected and the abundance of the fragments raise
the possibility that they may play a functional role, at least
for some snoRNA molecules. Indeed, there is experimen-
tal evidence that a small number of these sdRNAs may
have a functional role in the regulation of either splicing,
or translation (11,14,15,17). Here, we investigated the
characteristics of sdRNAs in diverse human cell types
and the potential effects of speciﬁc sdRNAs on expression
of separate spliced isoforms.
Through detailed analysis of small RNA data sets
derived from various human cell types we detected con-
servation of box C/D snoRNA-processing patterns
(Figures 3, 4 and 6). This agrees with the results of
recent experiments from other studies, suggesting that
some highly conserved components from the RNA
silencing processing machinery might be involved in the
generation of sdRNAs (14,15,22). Interestingly, however,
different species of sdRNAs from a given snoRNA display
variable accumulation in a cell-speciﬁc manner (Figures 3,
4 and 6). While RNA data sets for each cell line and
cell culture examined were represented by only one repli-
cate, the snoRNA-processing and sdRNA-accumulation
patterns were conserved between groups of related cell
types, suggesting that the trends observed are representa-
tive. The binding partners of the sdRNAs (both target
nucleic acid sequences and binding proteins), which are
present in varying and cell-speciﬁc amounts, will likely
inﬂuence the stability and the strength of the sdRNA ac-
cumulation. As more binding partners and targets are
identiﬁed, it will become possible to investigate this hy-
pothesis in a cell-speciﬁc manner.
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Figure 7. HBII-180C targets and the regulation of splicing of FGFR3. (A) The M-box region of HBII-180C is complementary to intronic regions in
the HIPPI and FGFR3 genes. (B) Sequence and diagram of the antisense plasmid (wild-type and mutant), designed to suppress expression/activity of
endogenous HBII-180C snoRNA. For the mutant construct the complementary region of FGFR3 was changed from CCTC to TTAT (grey, FRm).
(C) The endogenous FGFR3 alternatively spliced mRNA isoform pattern expressed in HeLa cells was changed by overexpression of the FGFR3
mini gene described in B. The gel image shows the results of RT–PCR with transfected empty plasmid pcDNA3.1 (Ctrl, lane 1), wild-type antisense
RNA (FR3, lane 2) mutant antisense RNA (FRm, lane 3), and reverse transcription control for HBII-180C (RT±, lanes 4 and 5). FGFR3 RNA
isoforms are indicated by arrows. Loading controls correspond to GAPDH mRNA and HBII-180C snoRNA, respectively. (D) Decrease of the
expression level of endogenous FGFR3 8–10 isoform by overexpression of HBII-180C in HeLa cells. The graph shows the signal intensity ratio of
FGFR3 8–10 isoform by qRT–PCR after overexpression of either wild-type (WT) HBII-180C or mutant HBII-180C (HBII-180C box D mut). (E)
Comparison of the alternative splicing pattern of endogenous FGFR3 in WI38 and HeLa cells. WI38 cells express endogenous HBII-180C at
signiﬁcantly lower levels than HeLa cells and display accumulation of the 8–10 isoform.
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When small RNAs derived from snoRNAs were initially
identiﬁed, they were widely dismissed as RNA degrad-
ation products. If this is correct, it predicts that sdRNA
proﬁles will be similar to the degradation proﬁles of other
abundant RNAs and different to miRNA proﬁles. We
tested this and our analyses support the view that at
least some sdRNAs arise via directed processing rather
than degradation and also shows their accumulations are
conserved across different cell types for a large number of
snoRNAs. Simple RNA degradation proﬁles would be
expected to display a higher degree of randomness,
lack conservation and show a stronger accumulation of
stable duplex-forming regions. All these characteristics
are visible in the rRNA and snRNA-processing proﬁles
examined. In contrast, many snoRNA-processing
proﬁles resemble instead miRNA-processing proﬁles,
showing a strong accumulation of one well-deﬁned
region of the full-length molecule (generally a portion of
one side of the main hairpin), which is conserved across
either most, or all, cell types examined. These snoRNA-
processing proﬁles suggest sdRNAs arise from speciﬁc
cleavage and protection from further processing, as is
seen for miRNAs, rather than degradation. The conserva-
tion of processing patterns has recently been independent-
ly reported for a subset of box C/D snoRNAs (members
of the HBII-52 and HBII-85 families) (11,43). Consistent
with these analyses, a small number of sdRNAs derived
from diverse snoRNAs have been recently shown
to display functionality and affect gene expression
(11,14,15,17,18,26).
A comparison of the read counts of sdRNAs to those of
longer forms of snoRNAs (>50nt) as available from ref.
(44) also provides clues about the prominence and relative
abundance of sdRNAs with respect to other snoRNA
forms. Among the snoRNAs with high-sdRNA read
counts (at least 10 read counts in at least 10 data sets),
approximately half (52%) express moderate-to-high levels
of longer forms including full-length snoRNA molecules.
The remaining half (48%) express low or non-detectable
levels of longer forms and are of particular interest as they
represent genomic loci displaying low accumulation of
full-length snoRNAs. These genomic loci thus appear to
serve either predominantly, or uniquely, for the produc-
tion of sdRNAs. Indeed, many sdRNAs encoded in these
loci display accumulation proﬁles resembling those of
miRNAs with stable and conserved accumulation of
speciﬁc regions of the snoRNA, as seen in Figure 4.
Conversely, another group of snoRNAs display low
levels of sdRNAs. Among these, approximately half ori-
ginate from genomic loci that express strongly longer
forms of snoRNAs (>50nt), and might represent
genomic regions serving mainly in the production of
full-length snoRNAs, or long forms of processed
snoRNAs such as those resulting from the HBII-52
locus as described in ref. (11). The remaining snoRNAs
originate from genomic loci expressing low levels of all
products (both long and short forms). Thus as described
previously (22), the levels of full-length snoRNAs often do
not correlate with the levels of their corresponding
sdRNAs, likely reﬂecting variability in expression and
processing regulation. While some genomic loci appear
to serve principally in the production of full-length
snoRNAs, others might mainly produce sdRNAs.
Similarly, the analysis of snoRNA processing provides
clues as to the potential functional role of the different
snoRNA fragments. While the functional speciﬁcity of
classical full-length snoRNAs is conferred by the guide
(antisense) region, a large majority of sdRNAs (88%
averaged over all snoRNAs considered) do not contain
the full-guide region from their parental snoRNA
(Figures 3 and 6). In contrast, other characteristic
features, in particular the box C, are highly represented
in sdRNAs. This is in agreement with recent studies that
identify box C in many sdRNAs (23), and in particular in
several sdRNAs capable of gene silencing (15). Regions
containing box D and in particular those not harboring
a known guide sequence immediately upstream, are also
represented in sdRNAs. Thus in general, snoRNA regions
that carry out classical snoRNA guide functions can differ
from those generating stably accumulating sdRNAs.
snoRNAs have been described as mobile genetic
elements capable of copying themselves to other genomic
locations (45,46), thus providing large numbers of poten-
tial sdRNA precursors. As a consequence, many families
of snoRNAs include several identical and near identical
copies. It is possible that this redundancy ensures a sufﬁ-
cient amount of full-length guide molecules for the
targeted, site-speciﬁc post-transcriptional modiﬁcation of
rRNA and other such substrates, while also providing
starting material for the generation of sdRNAs.
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